New Genetic Markers and Vitamin B3 Offer Hope in Managing MASLD Progression
Researchers identify a genetic regulator, microRNA-93, that worsens MASLD, with vitamin B3 showing promise as an effective treatment to counteract disease progression.
Approximately 30% of the global population suffers from metabolic-associated fatty liver disease (MASLD), a condition previously lacking specific targeted treatments. Recent research has uncovered a genetic factor that contributes to the worsening of MASLD, highlighting the role of microRNA-93 (miR-93) in disease progression. This liver-expressed microRNA promotes lipid accumulation, inflammation, and fibrosis by inhibiting SIRT1, a critical gene involved in lipid metabolism.
A collaborative effort led by Professor Jang Hyun Choi from UNIST, alongside counterparts from Pusan National University and Ulsan University Hospital, revealed that elevated levels of miR-93 are found in both patients with fatty liver disease and relevant animal models. Molecular studies demonstrated that reducing miR-93 levels in mice resulted in decreased hepatic fat accumulation and improved insulin sensitivity and liver function. Conversely, overexpression of miR-93 exacerbated liver metabolic dysfunction.
Strikingly, drug screening identified niacin (vitamin B3) as the most effective FDA-approved medication to suppress miR-93. Treatment with niacin significantly lowered liver miR-93 levels and increased SIRT1 activity, which restored lipid metabolic pathways and helped normalize liver lipid balance. This suggests that niacin, a well-established medication, could be repurposed as a therapeutic agent for MASLD through modulation of this genetic pathway.
The findings underscore the potential of targeting specific microRNAs to treat fatty liver disease and demonstrate how an existing safe medication like vitamin B3 could be integrated into new treatment strategies. This research opens promising avenues for personalized therapy in MASLD, emphasizing the importance of molecular genetics in disease management.
Published in the journal Metabolism, the study highlights the clinical relevance of repurposing known drugs for new indications and provides a foundation for future therapeutic development in fatty liver disease.
Source: https://medicalxpress.com/news/2025-05-genetic-factor-worsening-masld-vitamin.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Killer Whales Demonstrate Compassion Through Food Sharing with Humans
Research reveals that killer whales, or orcas, exhibit a surprising level of social behavior by sharing food with humans, highlighting their intelligence and nurturing nature.
Innovative Foam Treatment Offers Rapid Relief for Itching and Persistent Scalp Psoriasis
A new foam formulation of roflumilast shows rapid itch relief and significant clearance of scalp and body psoriasis lesions in a clinical trial, offering a promising treatment option for patients with challenging psoriasis.
Genetic Inheritance and Parental Influence Play Key Role in Childhood Obesity
New research highlights the genetic and environmental influences of parents on their children's risk of obesity, emphasizing the dual role of inherited genes and maternal impact during adolescence.
